HSCS · HeartSciences Inc.
$4.88
+1.09 (+28.80%)
At close · Sep 17
Going-concern doubt
— flagged Sep 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt regarding the Company's ability to continue as a going concern.”View the 10-Q filed Sep 14, 2026
Market Cap
$13.80M
Shares
4.80M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$3.79
Open$3.45
Day$3.43–3.94
52W close$1.67–4.12
Avg vol 30d129K
Short int114K · 2.4% float · 1.0d
Short vol73%
Last earningsMar 16, 2026
DataJun 2022–Sep 2026
Filing10-Q · Sep 14
Up next
filed Sep 14, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$4,519
Trailing 12 months
Net income (TTM)
−$10.26M
Trailing 12 months
Revenue growth YoY
+10.5%
Year over year
Operating margin
-209,733.1%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$29,906
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+203.1%
Year over year · more shares
Price change (1Y)
+4.2%
Trailing year
Short interest
2.4%
Latest settlement · 1.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Strong Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 17.7 · elevated
Equity put/call 0.69
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+48%
above
Price vs 50-day avg
+40%
above
RSI (14)
64
neutral
MACD trend
Positive
52-week position
87%
near high
Momentum
relative strength
1-month return
+78%
trailing
6-month return
+53%
trailing
YTD return
+23%
this year
Relative strength
+39%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $3 › 200d $3 — 50d above 200d
Institutional flow
Accumulating
+13% holders QoQ · +5 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
2.38% of float · ▲ +125.2% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
17 holders — mid 3-yr range
Squeeze score
62
elevated · 0–100
Fundamentals
Revenue growth
−1%
Y/Y
Gross margin
59%
expanding
EPS growth
+50%
Y/Y
Free cash flow
$-7.4M
Quant / Vol
risk profile
Volatility
99%
annualized · 1-yr
Max drawdown
−55%
past year
ATR
9.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Jul 29, 2026
planned trajectory
Zcash direct cash mining cost
$40
run-rate, once new machines are delivered and hashing
Adjusted EBITDA
Non-GAAP
at least $50M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+48%
Bullish
Price vs 50-day avg
+40%
Bullish
RSI (14)
64
Neutral
MACD trend
Positive
Bullish
52-week position
87%
Bullish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $3 › 200d $3 — 50d above 200d
Institutional flow
Accumulating
+13% holders QoQ · +5 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
2.38% of float · ▲ +125.2% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
17 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $2
Now $4 · 87%
Range high $4
vs 200-day avg +48%
vs 50-day avg +40%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
HSCS
this stock
HeartSciences Inc.
|
$13.80M | +22.7% | -0.7% | — | 2.4% |
|
ABT
Abbott Laboratories
|
$177.72B | -18.3% | +5.7% | 28.6 | 1.3% |
|
MDT
Medtronic plc
|
$119.98B | -3.6% | +8.4% | 23.1 | 0.9% |
|
SYK
Stryker Corp
|
$108.13B | -19.0% | +11.2% | 29.2 | 2.0% |
|
BSX
Boston Scientific Corp
|
$64.27B | -53.9% | +12.5% | 18.0 | 3.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| HSCS | -8.0% | +77.9% | +53.4% | +20.3% | +22.7% |
| SPY | -1.1% | -1.8% | +14.8% | -1.7% | +10.6% |
| vs SPY | -6.9% | +79.7% | +38.6% | +22.0% | +12.1% |